November 08, 2016 IRVINE, Calif. & KARLSRUHE, Germany–(BUSINESS WIRE)–joimax®, the global acting German developer and marketer of technologies and training methods for endoscopic minimally-invasive spinal surgery, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Vaporflex® and Legato® electrosurgical probes with radiowave technology for open and endoscopic spine surgery. […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone